Avacta Group acquires Coris BioConcept for £7.4m
Avacta Group has acquired Coris BioConcept for £7.4 million ($9.2 million) with an earnout based on future business performance, payable …
Privacy and compliance in the medical industry: how firms can walk the tightrope
The medical devices industry has been subject to a growing number of challenging regulations over recent decades. On one side …
Getinge bids up to $290m to buy High Purity New England
Swedish company Getinge has announced plans to take over High Purity New England (HPNE) in a deal worth up to $290 …
Neogen introduces two new assays to detect histamine
US-based Neogen has introduced two new histamine detection assays, namely Reveal for Histamine and Reveal Q+ for Histamine. Using a simple …
Labcorp introduces new liquid biopsy test
Global life sciences company Labcorp has introduced a new liquid biopsy test called Labcorp Plasma Focus. The new test enables the …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Twist Bioscience and CeGaT roll out new RNA fusion panel
Twist Bioscience, in partnership with clinical sequencing services provider CeGaT, has introduced the Twist Alliance CeGaT RNA Fusion Panel for …
The future of tissue regeneration through 3D bioprinting
Researchers working in tissue engineering are increasingly utilising 3D printers to fabricate personalised, miniature scaffolds onto which cells are placed. …
Nalu Medical enrols first patient in peripheral nerve stimulation study
US-based Nalu Medical has enrolled the first patient in its COMFORT-2 peripheral nerve stimulation (PNS) randomised controlled study for a …
Mainz Biomed selects TESTDNA to commercialise ColoAlert test in Poland
Molecular genetics diagnostic company Mainz Biomed has entered a commercial partnership with TESTDNA for its ColoAlert test in Poland. Mainz Biomed …
IDgenetix test shows increase in medication response and remission in study
Castle Biosciences’ IDgenetix pharmacogenomic test has showcased significant improvement in medication response and remission rates in patients with depressive disorder …
Who’s acquiring who? M&A activity in the medical devices industry in Asia-Pacific increased by 30% in Q1 2023
In the Asia-Pacific medical devices industry, there were 30 M&A deals announced in Q1 2023, worth a total value of …
Who’s acquiring who? M&A activity in the medical devices industry in Europe increased by 19% in Q1 2023
In the European medical devices industry, there were 44 M&A deals announced in Q1 2023, worth a total value of …
Who’s investing where? Private equity deal activity in the medical devices industry in North America decreased by 18% in Q1 2023
In the North American medical devices industry, there were 14 private equity deals announced in Q1 2023, worth a total …
Who’s acquiring who? M&A activity in the medical devices industry in North America decreased by 15% in Q1 2023
In the North American medical devices industry, there were 71 M&A deals announced in Q1 2023, worth a total value …
Who’s investing where? Private equity deal activity in the medical devices industry decreased by 37% in Q1 2023
In the global medical devices industry, there were 24 private equity deals announced in Q1 2023, worth a total value …